Storia in 2 fonti

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks

Nature Medicine retracts China lung cancer immunotherapy timing paper, citing data integrity concerns — and the fallout could fuel US anti-China sentiment in biopharma.

Raccontata da

medpagetoday.com

endpoints.news

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo1 mese fa

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks

Nature Medicine retracts China lung cancer immunotherapy timing paper, citing data integrity concerns — and the fallout could fuel US anti-China sentiment in biopharma.

originale

medpagetoday.com1 mese fa

Nature Retracts Cancer Study Linking Treatment Timing to Survival

Editors 'no longer have confidence in the integrity of the results'

Leggi questa versione → originale

Timeline cronologica

mercoledì 24 giugno 2026·medpagetoday.com
Nature Retracts Cancer Study Linking Treatment Timing to Survival
Editors 'no longer have confidence in the integrity of the results'
giovedì 25 giugno 2026·endpoints.news
Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks
Nature Medicine retracts China lung cancer immunotherapy timing paper, citing data integrity concerns — and the fallout could fuel US anti-China sentiment in biopharma.